Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $4.03 billion. The enterprise value is $6.44 billion.
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | Nov 15, 2024 |
Share Statistics
SBRA has 236.59 million shares outstanding. The number of shares has increased by 1.87% in one year.
| Current Share Class | 236.59M |
| Shares Outstanding | 236.59M |
| Shares Change (YoY) | +1.87% |
| Shares Change (QoQ) | +1.41% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 96.43% |
| Float | 233.18M |
Valuation Ratios
The trailing PE ratio is 41.75 and the forward PE ratio is 25.44. SBRA's PEG ratio is 0.37.
| Price/FFO Ratio | 13.03 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 41.75 |
| Forward PE | 25.44 |
| PS Ratio | 5.80 |
| Forward PS | 5.56 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | 13.03 |
| P/OCF Ratio | 13.03 |
| PEG Ratio | 0.37 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.84, with an EV/FCF ratio of 20.81.
| EV / Earnings | 66.24 |
| EV / Sales | 9.43 |
| EV / EBITDA | 15.84 |
| EV / EBIT | 26.59 |
| EV / FCF | 20.81 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.90.
| Current Ratio | 1.09 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | 6.08 |
| Debt / FCF | 8.01 |
| Interest Coverage | 2.10 |
Financial Efficiency
Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 2.90%.
| Return on Equity (ROE) | 3.46% |
| Return on Assets (ROA) | 2.82% |
| Return on Capital (ROIC) | 2.90% |
| Revenue Per Employee | $14.22M |
| Profits Per Employee | $2.02M |
| Employee Count | 48 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $1.12 million in taxes.
| Income Tax | 1.12M |
| Effective Tax Rate | 1.14% |
Stock Price Statistics
The stock price has increased by +19.41% in the last 52 weeks. The beta is 1.23, so SBRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +19.41% |
| 50-Day Moving Average | 18.31 |
| 200-Day Moving Average | 16.37 |
| Relative Strength Index (RSI) | 37.82 |
| Average Volume (20 Days) | 2,089,524 |
Short Selling Information
The latest short interest is 19.47 million, so 8.23% of the outstanding shares have been sold short.
| Short Interest | 19.47M |
| Short Previous Month | 18.50M |
| Short % of Shares Out | 8.23% |
| Short % of Float | 8.35% |
| Short Ratio (days to cover) | 9.73 |
Income Statement
In the last 12 months, SBRA had revenue of $682.32 million and earned $97.17 million in profits. Earnings per share was $0.41.
| Revenue | 682.32M |
| Gross Profit | 466.00M |
| Operating Income | 242.10M |
| Pretax Income | 54.12M |
| Net Income | 97.17M |
| EBITDA | 406.47M |
| EBIT | 242.10M |
| Earnings Per Share (EPS) | $0.41 |
Full Income StatementBalance Sheet
The company has $73.31 million in cash and $2.48 billion in debt, giving a net cash position of -$2.41 billion or -$10.17 per share.
| Cash & Cash Equivalents | 73.31M |
| Total Debt | 2.48B |
| Net Cash | -2.41B |
| Net Cash Per Share | -$10.17 |
| Equity (Book Value) | 2.74B |
| Book Value Per Share | 11.60 |
| Working Capital | 10.49M |
Full Balance SheetCash Flow
| Operating Cash Flow | 309.31M |
| Capital Expenditures | n/a |
| Free Cash Flow | 309.31M |
| FCF Per Share | $1.31 |
Full Cash Flow StatementMargins
Gross margin is 68.30%, with operating and profit margins of 35.48% and 14.24%.
| Gross Margin | 68.30% |
| Operating Margin | 35.48% |
| Pretax Margin | 14.41% |
| Profit Margin | 14.24% |
| EBITDA Margin | 59.57% |
| EBIT Margin | 35.48% |
| FCF Margin | 45.33% |